Compare Nu Holdings Ltd (NU) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

NU Holdings stock trades at $15.33, down slightly by 0.26% today, with a bullish technical signal from moving averages and a consensus analyst price target of $17.20. The company reported strong Q2 2026 results, including a 39% revenue growth and record net income exceeding $1 billion, driven by expanding customer base and AI integration. Cash flow from operations reached $3.5 billion in 2025, supporting robust financial health.

Outlook remains positive with growth opportunities in Mexico and AI-driven efficiencies, but risks include credit quality concerns and competitive pressures. Analysts are predominantly bullish, with 57% recommending buy, though investors should monitor debt levels and macroeconomic factors affecting fintech sectors.

XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.

The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.